| Issue Date | Title | Author(s) |
| 1-Jan-2011 | Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload | Dudley J. Pennell; John B. Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi Kong Li; Vip Viprakasit; Mohsen Saleh Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher; Royal Brompton Hospital; UCL; Universita degli Studi di Milano; University of Malaya Medical Centre; Cairo University; Ege University Medical School; Kuala Lumpur Hospital; Prince of Wales Hospital Hong Kong; Mahidol University; Ain Shams University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; American University of Beirut |
| 1-Jun-2012 | Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major | Dudley J. Pennell; John B. Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi Kong Li; Vip Viprakasit; Mohsen S. Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher; Royal Brompton Hospital; UCL; Universita degli Studi di Milano; University of Malaya Medical Centre; Cairo University; Ege Universitesi; Kuala Lumpur Hospital; Prince of Wales Hospital Hong Kong; Mahidol University; Ain Shams University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; American University of Beirut |
| 2-Aug-2012 | Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-Year results from a prospective, randomized, double-blind, placebo-controlled study | Ali T. Taher; John Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Renzo Galanello; Zeynep Karakas; Tomasz Lawniczek; Jacqueline Ros; Yiyun Zhang; Dany Habr; Maria Domenica Cappellini; American University of Beirut; UCL; Mahidol University; University of Athens; Chulalongkorn University; Universita degli Studi di Cagliari; Istanbul Tip Fakultesi; Novartis International AG; Novartis Pharmaceuticals; Universita degli Studi di Milano |
| 1-Feb-2019 | Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO <sup>©</sup> ) | Ali Taher; Vip Viprakasit; Maria Domenica Cappellini; Pranee Sutcharitchan; Richard Ward; Dalia Mahmoud; Abderrahmane Laadem; Anzalee Khan; Chad Gwaltney; Gale Harding; Kenneth Attie; Xiaosha Zhang; Jun Zou; Joseph Pariseau; X. Henry Hu; Antonis Kattamis; Evidera, USA; American University of Beirut Medical Center; Università degli Studi di Milano; Chulalongkorn University; Aghia Sophia Children's Hospital; Celgene Corporation; University of Toronto; Faculty of Medicine, Siriraj Hospital, Mahidol University; Nathan S. Kline Institute for Psychiatric Research; NeuroCog Trials; ERT; Acceleron Pharma |
| 18-Jan-2013 | Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemias | Vip Viprakasit; Norbert Gattermann; Jong Wook Lee; John B. Porter; Ali T. Taher; Dany Habr; Nicolas Martin; Gabor Domokos; Maria Domenica Cappellini; Mahidol University; Heinrich Heine Universitat; The Catholic University of Korea; UCL; American University of Beirut; Novartis Pharmaceuticals; Novartis International AG; Universita degli Studi di Milano |
| 1-Feb-2014 | Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): A status quo | Ali T. Taher; Khaled M. Musallam; Vip Viprakasit; John B. Porter; Maria Domenica Cappellini; American University of Beirut Medical Center; Mahidol University; UCL; Universita degli Studi di Milano |
| 1-Jan-2014 | An overview of current treatment strategies for β-thalassemia | Maria Domenica Cappellini; Vip Viprakasit; Ali T. Taher; Universita degli Studi di Milano; Mahidol University; American University of Beirut |
| 1-Jul-2018 | A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? | Maria Domenica Cappellini; John B. Porter; Vip Viprakasit; Ali T. Taher; American University of Beirut Medical Center; Università degli Studi di Milano; UCL; Faculty of Medicine, Siriraj Hospital, Mahidol University |
| 1-Oct-2019 | Quality of life in patients with β-thalassemia: A prospective study of transfusion-dependent and non-transfusion-dependent patients in Greece, Italy, Lebanon, and Thailand | Maria Domenica Cappellini; Antonis Kattamis; Vip Viprakasit; Pranee Sutcharitchan; Joseph Pariseau; Abderrahmane Laadem; Valerie Jessent-Ciaravino; Ali Taher; American University of Beirut Medical Center; Università degli Studi di Milano; King Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn University; Aghia Sophia Children's Hospital; Celgene Corporation; Faculty of Medicine, Siriraj Hospital, Mahidol University |
| 1-Apr-2010 | Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias | Maria Domenica Cappellini; John Porter; Amal El-Beshlawy; Chi Kong Li; John F. Seymour; Mohsen Elalfy; Norbert Gattermann; Stéphane Giraudier; Jong Wook Lee; Lee Lee Chan; Kai Hsin Lin; Christian Rose; Ali Taher; Swee Lay Thein; Vip Viprakasit; Dany Habr; Gabor Domokos; Bernard Roubert; Antonis Kattamis; Universita degli Studi di Milano; UCL; Cairo University; Prince of Wales Hospital Hong Kong; Peter Maccallum Cancer Centre; Ain Shams University; Heinrich Heine Universitat; Hopital Henri Mondor; The Catholic University of Korea; University of Malaya Medical Centre; National Taiwan University Hospital; Hopital Saint-Vincent-de-Paul; American University of Beirut; King's College London; Mahidol University; Novartis Pharmaceuticals Corporation; Novartis International AG; University of Athens |
| 1-Feb-2019 | Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO <sup>©</sup> ) | Ali Taher; Maria Domenica Cappellini; Vip Viprakasit; Pranee Sutcharitchan; Dalia Mahmoud; Abderrahmane Laadem; Anzalee Khan; Chad Gwaltney; Gale Harding; Kenneth Attie; Xiaosha Zhang; Jun Zou; Joseph Pariseau; X. Henry Hu; Antonis Kattamis; Evidera, USA; American University of Beirut Medical Center; Università degli Studi di Milano; Chulalongkorn University; Aghia Sophia Children's Hospital; Celgene Corporation; Faculty of Medicine, Siriraj Hospital, Mahidol University; Nathan S. Kline Institute for Psychiatric Research; NeuroCog Trials; ERT; Acceleron Pharma |
